Creative Planning Boosts Stock Position in The Cooper Companies, Inc. (NYSE:COO)

Posted by Defense World Staff on Oct 14th, 2023

Creative Planning boosted its holdings in The Cooper Companies, Inc. (NYSE:COO – Free Report) by 14.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,682 shares of the medical device company’s stock after purchasing an additional 468 shares during the period. Creative Planning’s holdings in Cooper Companies were worth $1,412,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of COO. KB Financial Partners LLC purchased a new position in shares of Cooper Companies during the 1st quarter valued at $34,000. Clear Street Markets LLC lifted its position in shares of Cooper Companies by 93.9% during the 1st quarter. Clear Street Markets LLC now owns 95 shares of the medical device company’s stock valued at $35,000 after buying an additional 46 shares during the last quarter. Colonial Trust Co SC purchased a new position in shares of Cooper Companies during the 1st quarter valued at $41,000. Trivant Custom Portfolio Group LLC purchased a new position in shares of Cooper Companies during the 1st quarter valued at $58,000. Finally, Desjardins Global Asset Management Inc. lifted its position in shares of Cooper Companies by 201.5% during the 1st quarter. Desjardins Global Asset Management Inc. now owns 202 shares of the medical device company’s stock valued at $75,000 after buying an additional 135 shares during the last quarter. Hedge funds and other institutional investors own 96.31% of the company’s stock.

Cooper Companies Price Performance

Shares of NYSE COO opened at $325.54 on Friday. The firm has a market capitalization of $16.12 billion, a P/E ratio of 58.87, a P/E/G ratio of 2.43 and a beta of 0.94. The company has a quick ratio of 0.99, a current ratio of 1.72 and a debt-to-equity ratio of 0.33. The stock’s 50-day simple moving average is $348.33 and its two-hundred day simple moving average is $367.51. The Cooper Companies, Inc. has a twelve month low of $248.10 and a twelve month high of $399.62.

Cooper Companies (NYSE:COO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 30th. The medical device company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.34 by $0.01. The firm had revenue of $930.20 million for the quarter, compared to analyst estimates of $899.77 million. Cooper Companies had a return on equity of 8.17% and a net margin of 7.83%. The company’s revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the company earned $3.19 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 12.81 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Robert W. Baird upped their price target on Cooper Companies from $400.00 to $410.00 and gave the company an “outperform” rating in a research report on Thursday, August 31st. Redburn Atlantic cut Cooper Companies from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $390.00 to $343.00 in a report on Thursday, October 5th. Citigroup dropped their price objective on Cooper Companies from $440.00 to $420.00 in a report on Monday, October 2nd. TheStreet cut Cooper Companies from a “b-” rating to a “c+” rating in a report on Friday, June 16th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $420.00 price objective on shares of Cooper Companies in a report on Thursday, August 31st. Three analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $403.67.

Check Out Our Latest Stock Report on Cooper Companies

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.